|
POGK expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.585000E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.121600E-01 |
| Normal-vs-Stage2 |
2.518300E-02 |
| Normal-vs-Stage3 |
4.528200E-01 |
| Normal-vs-Stage4 |
5.439600E-01 |
| Stage1-vs-Stage2 |
6.638000E-02 |
| Stage1-vs-Stage3 |
9.352000E-01 |
| Stage1-vs-Stage4 |
1.935770E-01 |
| Stage2-vs-Stage3 |
1.144180E-01 |
| Stage2-vs-Stage4 |
1.068260E-02 |
| Stage3-vs-Stage4 |
2.221800E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.793800E-01 |
| Normal-vs-AfricanAmerican |
1.956620E-01 |
| Normal-vs-Asian |
9.708200E-01 |
| Caucasian-vs-AfricanAmerican |
6.412400E-02 |
| Caucasian-vs-Asian |
6.167600E-01 |
| AfricanAmerican-vs-Asian |
1.835570E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.891400E-01 |
| Normal-vs-Female |
4.454600E-01 |
| Male-vs-Female |
5.909600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.631800E-01 |
| Normal-vs-Age(41-60Yrs) |
1.857420E-01 |
| Normal-vs-Age(61-80Yrs) |
6.167400E-01 |
| Normal-vs-Age(81-100Yrs) |
4.010200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.877000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.925600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.349400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.802800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.747800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.756600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.727600E-01 |
| Classical-VS-Follicular |
1.36099997938288E-09 |
| Classical-VS-Other |
3.030800E-01 |
| Classical-VS-Normal |
5.252000E-01 |
| Tall-VS-Follicular |
9.803900E-04 |
| Tall-VS-Other |
3.912800E-01 |
| Tall-VS-Normal |
9.347000E-01 |
| Follicular-VS-Other |
3.223800E-01 |
| Follicular-VS-Normal |
1.035760E-04 |
| Other-VS-Normal |
3.842600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.370160E-02 |
| Normal-vs-N1 |
7.701200E-01 |
| N0-vs-N1 |
8.961800E-02 |
|
|
